Vapotherm
Payments companies reported to CMS as associated with Vapotherm. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Vapotherm, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Vapotherm
These are the largest totals companies reported as associated with Vapotherm. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Jaime Betancourt | Los Angeles, CA | Internal Medicine | $31,668.00 |
| Fariborz Rezai | Livingston, NJ | Critical Care Medicine (Internal Medicine) | $28,565.74 |
| Jeremy Greenberg | Chattanooga, TN | Critical Care Medicine (Internal Medicine) | $16,863.61 |
| Michael Gonzalez | Jersey Village, TX | Emergency Medicine | $16,548.81 |
| David Yamane | Washington, DC | Emergency Medicine | $13,209.85 |
| Ari Ciment | Miami Beach, FL | Pulmonary Disease | $11,234.34 |
| Richard Betters | Springfield, MO | Pediatric Critical Care Medicine | $8,883.00 |
| Adam Hennessey | Camden, NJ | Emergency Medicine | $5,305.00 |
| John Misdary | Rapid City, SD | Emergency Medicine | $3,066.37 |
| Andrew Meltzer | Washington, DC | Emergency Medicine | $2,877.74 |
Prescribed Vapotherm?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.